GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » 9-Day RSI

SPO Global (SPO Global) 9-Day RSI : 65.36 (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is SPO Global 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-05-24), SPO Global's 9-Day RSI is 65.36.

The industry rank for SPO Global's 9-Day RSI or its related term are showing as below:

SPOM's 9-Day RSI is ranked worse than
78.89% of 597 companies
in the Conglomerates industry
Industry Median: 50.67 vs SPOM: 65.36

Competitive Comparison of SPO Global's 9-Day RSI

For the Conglomerates subindustry, SPO Global's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SPO Global's 9-Day RSI Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, SPO Global's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where SPO Global's 9-Day RSI falls into.



SPO Global  (OTCPK:SPOM) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SPO Global  (OTCPK:SPOM) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


SPO Global 9-Day RSI Related Terms

Thank you for viewing the detailed overview of SPO Global's 9-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


SPO Global (SPO Global) Business Description

Traded in Other Exchanges
N/A
Address
Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634
SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.
Executives
Jeffrey Louis Feuer officer: Chief Financial Officer 21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan officer: Chief Operating Officer 21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold director, officer: Chief Executive Officer C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun director SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman director 183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi 10 percent owner, officer: Chief Technology Officer C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367